The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?

[1]  V. Dubowitz,et al.  Muscle Biopsy: A Practical Approach , 2020 .

[2]  T. Klopstock,et al.  Mitochondriale Erkrankungen , 2019, Der Nervenarzt.

[3]  J. Winkler,et al.  VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease , 2017, Neurology.

[4]  A. Ludolph,et al.  Genetic analysis of VCP and WASH complex genes in a German cohort of sporadic ALS-FTD patients , 2017, Neurobiology of Aging.

[5]  W. H. Goldmann,et al.  Early signs of architectural and biomechanical failure in isolated myofibers and immortalized myoblasts from desmin-mutant knock-in mice , 2017, Scientific Reports.

[6]  A. Noegel,et al.  Structural and functional diversity of novel coronin 1 C ( CRN 2 ) isoforms in muscle , 2017 .

[7]  R. Kley,et al.  New aspects of myofibrillar myopathies. , 2016, Current opinion in neurology.

[8]  Robert W. Taylor,et al.  Mitochondrial dysfunction in myofibrillar myopathy , 2016, Neuromuscular Disorders.

[9]  A. Franke,et al.  Neuromuscular endplate pathology in recessive desminopathies , 2016, Neurology.

[10]  F. Kerling,et al.  Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients , 2016, Stroke.

[11]  V. Kimonis,et al.  215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13–15 November 2015, Heemskerk, The Netherlands , 2016, Neuromuscular Disorders.

[12]  R. Kley,et al.  Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue , 2016, Acta Neuropathologica.

[13]  L. Eichinger,et al.  Mutant p97 exhibits species-specific changes of its ATPase activity and compromises the UBXD9-mediated monomerisation of p97 hexamers. , 2016, European journal of cell biology.

[14]  U. Schlötzer-Schrehardt,et al.  Downstream effects of plectin mutations in epidermolysis bullosa simplex with muscular dystrophy , 2016, Acta neuropathologica communications.

[15]  H. Katus,et al.  AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice , 2016, Gene Therapy.

[16]  M. Tegenthoff,et al.  New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses , 2016, Acta neuropathologica communications.

[17]  U. Schlötzer-Schrehardt,et al.  Myofibrillar instability exacerbated by acute exercise in filaminopathy. , 2015, Human molecular genetics.

[18]  R. Sauer,et al.  An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication , 2015, Protein science : a publication of the Protein Society.

[19]  W. Rottbauer,et al.  VCP and PSMF1: Antagonistic regulators of proteasome activity. , 2015, Biochemical and biophysical research communications.

[20]  G. Haaker,et al.  Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers , 2015, Klinische Pädiatrie.

[21]  W. Rottbauer,et al.  In vivo characterization of human myofibrillar myopathy genes in zebrafish. , 2015, Biochemical and biophysical research communications.

[22]  V. Kimonis,et al.  Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease. , 2015, Human gene therapy methods.

[23]  W. Rottbauer,et al.  The toxic effect of R350P mutant desmin in striated muscle of man and mouse , 2014, Acta Neuropathologica.

[24]  S. Blanton,et al.  A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. , 2014, Brain : a journal of neurology.

[25]  H. Meyer,et al.  The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis , 2014, Journal of Cell Science.

[26]  G. Haaker,et al.  C9ORF72‐ALS: P62‐ and ubiquitin‐aggregation pathology in skeletal muscle , 2014, Muscle & nerve.

[27]  Henry J. Lin,et al.  Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains. , 2014, Journal of molecular biology.

[28]  E. Perlas,et al.  Severe protein aggregate myopathy in a knockout mouse model points to an essential role of cofilin2 in sarcomeric actin exchange and muscle maintenance. , 2014, European journal of cell biology.

[29]  W. H. Goldmann,et al.  Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle. , 2014, The Journal of clinical investigation.

[30]  Shiwen Luo,et al.  Cdc48: A Swiss Army Knife of Cell Biology , 2013, Journal of amino acids.

[31]  M. Tegenthoff,et al.  Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. , 2013, Journal of proteomics.

[32]  F. Chapon,et al.  Hereditary myopathy with early respiratory failure: occurrence in various populations , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  D. Gozuacik,et al.  A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization. , 2013, The international journal of biochemistry & cell biology.

[34]  H. J. Schelhaas,et al.  Hereditary spastic paraplegia caused by a mutation in the VCP gene. , 2012, Brain : a journal of neurology.

[35]  D. Goldstein,et al.  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis , 2012, Neurology.

[36]  S. Strelkov,et al.  Desminopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[37]  L. Eichinger,et al.  Heteromeric p97/p97R155C Complexes Induce Dominant Negative Changes in Wild-Type and Autophagy 9-Deficient Dictyostelium strains , 2012, PloS one.

[38]  R. Edwards,et al.  The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology , 2012, PloS one.

[39]  L. Eichinger,et al.  Reply: Hereditary spastic paraplegia caused by a mutation in the VCP gene VCP: A Jack of all trades in neuro- and myodegeneration? , 2012 .

[40]  H. Fuchs,et al.  Innovations in phenotyping of mouse models in the German Mouse Clinic , 2012, Mammalian Genome.

[41]  V. Kimonis,et al.  Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice , 2012, Cell Death and Disease.

[42]  J. Bronstein,et al.  Valosin-containing protein mutation and Parkinson's disease. , 2012, Parkinsonism & related disorders.

[43]  R. Schröder.  Protein aggregate myopathies: the many faces of an expanding disease group , 2012, Acta Neuropathologica.

[44]  J. Gieseke,et al.  Characterization of the failing murine heart in a desmin knock-out model using a clinical 3 T MRI scanner , 2012, The International Journal of Cardiovascular Imaging.

[45]  U. Ahting,et al.  Classical MERRF phenotype associated with mitochondrial tRNALeu (m.3243A>G) mutation , 2012, European Journal of Pediatrics.

[46]  R. Aebersold,et al.  Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations , 2011, Nature Cell Biology.

[47]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[48]  H. Fuchs,et al.  Mouse phenotyping. , 2011, Methods.

[49]  A. Schramm,et al.  Isolated ring-finger myoclonus , 2011, Journal of Neurology.

[50]  K. Herholz,et al.  Early signs of VCP-related frontotemporal dementia: a neuropsychological, FDG-PET and fMRI study , 2011, Journal of Neurology.

[51]  Sonja W. Scholz,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2010, Neuron.

[52]  D. Wallace,et al.  VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease , 2010, PloS one.

[53]  W. Rottbauer,et al.  Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases. , 2010, Brain : a journal of neurology.

[54]  F. Mastaglia,et al.  Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: Novel clinical and genetic findings , 2010, Neuromuscular Disorders.

[55]  A. Wright,et al.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. , 2010, Human molecular genetics.

[56]  R. Schröder,et al.  Proteasomal activity in skeletal muscle: a matter of assay design, muscle type, and age. , 2010, Analytical biochemistry.

[57]  B. Fleischmann,et al.  Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice , 2010, Journal of Interventional Cardiac Electrophysiology.

[58]  R. Schröder,et al.  Myosinspeichermyopathie: eine seltene Unterform der Proteinaggregationsmyopathien , 2010 .

[59]  A. Doerfler,et al.  Incontinetia pigmenti-related myopathy or unsolved “double trouble”? , 2010, Neuromuscular Disorders.

[60]  T. Struffert,et al.  Autosomal dominant nemaline myopathy caused by a novel α-tropomyosin 3 mutation , 2010, Journal of Neurology.

[61]  R. Hartmann-Petersen,et al.  New ATPase regulators--p97 goes to the PUB. , 2009, The international journal of biochemistry & cell biology.

[62]  M. Wattjes,et al.  Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole‐body 3.0‐T magnetic resonance imaging study , 2009, Acta neurologica Scandinavica.

[63]  B. Schoser,et al.  Myofibrillar Myopathies: A Clinical and Myopathological Guide , 2009, Brain pathology.

[64]  K. Claeys,et al.  Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia , 2009, Neuromuscular Disorders.

[65]  L. Eichinger,et al.  How much mutant protein is needed to cause a protein aggregate myopathy in vivo? Lessons from an exceptional desminopathy , 2009, Human mutation.

[66]  H. Fuchs,et al.  The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. , 2009, Current pharmaceutical biotechnology.

[67]  F.,et al.  Muscle fibres : applications for the study of the metabolic consequences of enzyme deficiencies in skeletal muscle , 2009 .

[68]  W. Oertel,et al.  Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy , 2009, Journal of Neurology.

[69]  A. Toga,et al.  Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2 , 2008, Journal of Neurology.

[70]  C. Heyer,et al.  Distinct muscle imaging patterns in myofibrillar myopathies , 2008, Neurology.

[71]  K. Claeys,et al.  Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene , 2008, Neuromuscular Disorders.

[72]  B. Wintersperger,et al.  Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies , 2008, Neuromuscular Disorders.

[73]  W. Kunz,et al.  Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms , 2008, The Journal of cell biology.

[74]  I. Blumcke,et al.  White matter angiopathy is common in pediatric patients with intractable focal epilepsies , 2008, Epilepsia.

[75]  R. Wiesner,et al.  Concerted action of two novel tRNA mtDNA point mutations in chronic progressive external ophthalmoplegia. , 2008, Bioscience reports.

[76]  Charles D. Smith,et al.  Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia , 2008, American journal of medical genetics. Part A.

[77]  M. von Falkenhausen,et al.  Suprascapular nerve entrapment by a spinoglenoid cyst , 2008, Neurology.

[78]  B. Fleischmann,et al.  Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. , 2007, Cardiovascular research.

[79]  T. Holak,et al.  CAP2, cyclase-associated protein 2, is a dual compartment protein , 2007, Cellular and Molecular Life Sciences.

[80]  M. Vorgerd,et al.  Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. , 2007, Brain : a journal of neurology.

[81]  W. Kress,et al.  Variability of the recessive oculopharyngeal muscular dystrophy phenotype , 2007, Muscle & nerve.

[82]  G. Warren,et al.  Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. , 2007, Biochemical and biophysical research communications.

[83]  E. Wanker,et al.  Pathological consequences of VCP mutations on human striated muscle. , 2007, Brain : a journal of neurology.

[84]  H. Urbach,et al.  [Cerebellar syndromes in Langerhans' cell histiocytosis]. , 2007, Der Nervenarzt.

[85]  B. Wirth,et al.  Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy , 2007, Neurogenetics.

[86]  H. Urbach,et al.  Global brain dysmyelination with above‐average verbal skills in 18q − syndrome with a 17 Mb terminal deletion , 2006, Acta neurologica Scandinavica.

[87]  A. Brunn,et al.  The inflammatory reaction pattern distinguishes primary dysferlinopathies from idiopathic inflammatory myopathies: an important role for the membrane attack complex , 2006, Acta Neuropathologica.

[88]  M. Latterich,et al.  p97: The cell's molecular purgatory? , 2006, Molecular cell.

[89]  I. Ferrer,et al.  Different early pathogenesis in myotilinopathy compared to primary desminopathy , 2006, Neuromuscular Disorders.

[90]  R. Isaacson,et al.  Conformational changes in the AAA ATPase p97–p47 adaptor complex , 2006, The EMBO journal.

[91]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[92]  S. Simon,et al.  Hsp27‐2D‐gel electrophoresis is a diagnostic tool to differentiate primary desminopathies from myofibrillar myopathies , 2005, FEBS letters.

[93]  Werner Müller,et al.  Introducing the German Mouse Clinic: open access platform for standardized phenotyping , 2005, Nature Methods.

[94]  M. Vorgerd,et al.  Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. , 2005, Human molecular genetics.

[95]  T. Klockgether,et al.  Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns–Sayre syndrome , 2005, Journal of Neurology.

[96]  T. Klockgether,et al.  Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo‐controlled, double‐blind 31P‐MRS crossover study , 2005, European journal of neurology.

[97]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[98]  H. Urbach,et al.  Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs , 2005, Journal of Neurology.

[99]  M. Hesse,et al.  Novel insights into intermediate-filament function from studies of transgenic and knockout mice , 2000, Protoplasma.

[100]  T. Klockgether,et al.  Diagnostic value of mitochondrial DNA mutation analysis in juvenile unilateral ptosis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[101]  S. Schmidt,et al.  The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif). , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[102]  C. Elger,et al.  Tissue dependent co-segregation of the novel pathogenic G12276A mitochondrial tRNALeu(CUN) mutation with the A185G D-loop polymorphism , 2004, Journal of Medical Genetics.

[103]  D. Fischer,et al.  On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy , 2004, Journal of Neurology.

[104]  T. Klockgether,et al.  Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2 , 2004, Journal of Neurology.

[105]  M. Vorgerd,et al.  FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients , 2004, Journal of Medical Genetics.

[106]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[107]  J. Uitto,et al.  Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation , 2004, European Journal of Pediatrics.

[108]  R. Fimmers,et al.  TP53 Gene Mutations, Nuclear p53 Accumulation, Expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) Proteins are not Prognostic Factors in De Novo Glioblastoma Multiforme , 2001, Journal of Neuro-Oncology.

[109]  H. Urbach,et al.  Cauda equina syndrome with multiple lumbar diverticula complicating long-standing ankylosing spondylitis , 1994, The clinical investigator.

[110]  S. Zierz,et al.  Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy , 1993, Clinical Investigation.

[111]  T. Klockgether,et al.  [Diagnostic value of mitochondrial DNA analysis in chronic progressive external ophthalmoplegia (CPEO)]. , 2004, Klinische Monatsblätter für Augenheilkunde.

[112]  A. Wernig,et al.  Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures , 2004, Cell and Tissue Research.

[113]  Rolf Schröder,et al.  Analysis of HLA class I and II alleles in sporadic inclusion-body myositis , 2003, Journal of Neurology.

[114]  D. Fischer,et al.  On symptomatic heterozygous alpha‐sarcoglycan gene mutation carriers , 2003, Annals of neurology.

[115]  D. Fischer,et al.  [Macrophagic myofasciitis: inflammatory, vaccination-associated muscular disease]. , 2003, Deutsche medizinische Wochenschrift.

[116]  I. Nonaka,et al.  Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods , 2003, Neuromuscular Disorders.

[117]  G. Rau,et al.  Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: A noninvasive 31P‐MRS and EMG study , 2003, Muscle & nerve.

[118]  S. Bosbach,et al.  Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 2003, Brain : a journal of neurology.

[119]  K. Zerres,et al.  On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. , 2003, Human molecular genetics.

[120]  H. Urbach,et al.  Consequences of a novel caveolin‐3 mutation in a large German family , 2003, Annals of neurology.

[121]  B. Delabarre,et al.  Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains , 2003, Nature Structural Biology.

[122]  T. Helliwell,et al.  The spectrum of pathology in central core disease , 2002, Neuromuscular Disorders.

[123]  A. May,et al.  Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle , 2002, Nature Structural Biology.

[124]  A. Brunn,et al.  Spinal schwannoma mimicking lower limb SMA. , 2002, Neurology.

[125]  C. Elger,et al.  Expression Pattern of Mitochondrial Respiratory Chain Enzymes in Skeletal Muscle of Patients Harboring the A3243G Point Mutation or Large‐Scale Deletions of Mitochondrial DNA , 2002, Journal of neuropathology and experimental neurology.

[126]  D. Fischer,et al.  Granulomatous myositis associated with antithyroglobulin and antithyroid peroxidase antibodies , 2002, Journal of Neurology.

[127]  P. F. van der Ven,et al.  Primary longitudinal adhesion structures: plectin-containing precursors of costameres in differentiating human skeletal muscle cells , 2002, Histochemistry and Cell Biology.

[128]  Christian E Elger,et al.  Metabolic consequences of a novel missense mutation of the mtDNA CO I gene. , 2002, Human molecular genetics.

[129]  C. Bönnemann,et al.  Expression, localization and functional divergence of αB-crystallin and heat shock protein 27 in core myopathies and neurogenic atrophy , 2002, Acta Neuropathologica.

[130]  S. Zierz,et al.  A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. , 2002, Molecular genetics and metabolism.

[131]  J. Malin,et al.  Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. , 2002, Archives of neurology.

[132]  S. Weis,et al.  Defective Mitochondrial Oxidative Phosphorylation in Myopathies with Tubular Aggregates Originating from Sarcoplasmic Reticulum , 2001, Journal of neuropathology and experimental neurology.

[133]  B. Fleischmann,et al.  Loss of Annexin A7 Leads to Alterations in Frequency-Induced Shortening of Isolated Murine Cardiomyocytes , 2001, Molecular and Cellular Biology.

[134]  Vivian X. Fu,et al.  Functional Analysis of the Trypanosomal AAA ProteinTbVCP with trans-Dominant ATP Hydrolysis Mutants* , 2001, The Journal of Biological Chemistry.

[135]  M. Bös,et al.  Zerebelläres Syndrom, Exophthalmus und sekundärer Hypogonadismus bei Erdheim-Chester-Erkrankung , 2001, Der Nervenarzt.

[136]  H. Reichmann,et al.  Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions , 2001, Neurology.

[137]  C. Bönnemann,et al.  Early and selective downregulation of telethonin in neurogenic atrophy , 2001 .

[138]  M. Vorgerd,et al.  Creatine supplementation results in elevated PCr/ATP ratios in the calf muscle of athletes but not in patients with myopathies , 2001 .

[139]  M van Heel,et al.  Structure of the AAA ATPase p97. , 2000, Molecular cell.

[140]  S. Kempa,et al.  Indications for a Novel Muscular Dystrophy Pathway , 2000, Journal of Cell Biology.

[141]  D. Fürst,et al.  Association of Plectin with Z-Discs Is a Prerequisite for the Formation of the Intermyofibrillar Desmin Cytoskeleton , 2000, Laboratory Investigation.

[142]  C. Elger,et al.  Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. , 2000, Analytical biochemistry.

[143]  J. Marini,et al.  Quantitative analysis of relative protein contents by Western blotting: Comparison of three members of the dystrophin‐glycoprotein complex in slow and fast rat skeletal muscle , 2000, Electrophoresis.

[144]  D. Mckearin,et al.  Identification of TER94, an AAA ATPase protein, as a Bam-dependent component of the Drosophila fusome. , 1999, Molecular biology of the cell.

[145]  I. Blümcke,et al.  Immunogold EM reveals a close association of plectin and the desmin cytoskeleton in human skeletal muscle. , 1999, European journal of cell biology.

[146]  C. Elger,et al.  Plectin in the human central nervous system: predominant expression at pia/glia and endothelia/glia interfaces , 1998, Acta Neuropathologica.

[147]  K. Zatloukal,et al.  Lessons from Keratin 18 Knockout Mice: Formation of Novel Keratin Filaments, Secondary Loss of Keratin 7 and Accumulation of Liver-specific Keratin 8-Positive Aggregates , 1998, The Journal of cell biology.

[148]  I. Blumcke,et al.  Altered distribution of plectin/HD1 in dystrophinopathies , 1997, Neuromuscular Disorders.

[149]  F. Jerusalem,et al.  Zerebrales Rezidiv eines Morbus Whipple nach Tetrazyklin-Therapie , 1995 .

[150]  C. Unkrig,et al.  Lorenzo's oil and lymphocytopenia. , 1994, New England Journal of Medicine.

[151]  D. Botstein,et al.  Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression , 1991, The Journal of cell biology.